Results 151 to 160 of about 286,552 (218)
[Papillary gingival hyperplasia].
Z, Pantelić +2 more
openaire +1 more source
Oral Angiolymphoid Hyperplasia With Eosinophilia Exhibiting Cutaneous-Type Histopathologic Features: Clinical Regression Following Hormonal Withdrawal and a 50-Year Review. [PDF]
Jesus PVS +8 more
europepmc +1 more source
Drug-induced gingival overgrowth: FAERS based real-world pharmacovigilance study and network pharmacology analysis. [PDF]
Zhu Q, Wu Z, Jiao X, Han L, Yuan Y.
europepmc +1 more source
Pseudoepitheliomatous Hyperplasia of the Medial Thigh with Dystrophic Calcification and Metaplastic Ossification: A Case Report. [PDF]
Oster LM +4 more
europepmc +1 more source
[Phenytoin and gingival hyperplasia].
H, Bostanci, N, Aksoy, N, Aydin
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Reappraising localized juvenile spongiotic gingival hyperplasia
Journal of the American Dental Association, 2019BACKGROUND Localized juvenile spongiotic gingival hyperplasia (LJSGH) is a gingival lesion of unknown cause. The purpose of this study is to present a series of LJSGH cases and compare the findings with the literature.
Elizabeth Ann Bilodeau
exaly +2 more sources
Oral surgery, oral medicine, oral pathology and oral radiology, 2020
OBJECTIVES Localized juvenile spongiotic gingival hyperplasia (LJSGH) is a recently described entity with distinct manifestations. Herein we report a comprehensive histopathologic study of 21 lesions and a literature review.
V. Theofilou +4 more
semanticscholar +1 more source
OBJECTIVES Localized juvenile spongiotic gingival hyperplasia (LJSGH) is a recently described entity with distinct manifestations. Herein we report a comprehensive histopathologic study of 21 lesions and a literature review.
V. Theofilou +4 more
semanticscholar +1 more source
Management of medication-induced gingival hyperplasia: a systematic review.
Oral surgery, oral medicine, oral pathology and oral radiology, 2020OBJECTIVE Medication-induced gingival hyperplasia (MIGH) has been linked to several medications, with a reported prevalence ranging between 0.5% and 85%.
H. Mawardi +6 more
semanticscholar +1 more source

